BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piccinin C, Panchal S, Watkins N, Kim RH. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Rev Anticancer Ther 2019;19:787-801. [PMID: 31469018 DOI: 10.1080/14737140.2019.1659730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Choi HG, Park JH, Choi YJ, Suh YJ. Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data. Int J Environ Res Public Health 2021;18:6409. [PMID: 34199253 DOI: 10.3390/ijerph18126409] [Reference Citation Analysis]
2 Ece Solmaz A, Yeniay L, Gökmen E, Zekioğlu O, Haydaroğlu A, Bilgen I, Özkınay F, Onay H. Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00070-7. [PMID: 33980423 DOI: 10.1016/j.clbc.2021.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bagwell AK, Sutton TL, Gardiner S, Johnson N. Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute. Am J Surg 2021;221:1159-63. [PMID: 33849710 DOI: 10.1016/j.amjsurg.2021.03.060] [Reference Citation Analysis]
4 Cozzi A, Schiaffino S, Giorgi Rossi P, Sardanelli F. Breast cancer screening: in the era of personalized medicine, age is just a number. Quant Imaging Med Surg 2020;10:2401-7. [PMID: 33269240 DOI: 10.21037/qims-2020-26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Saccarelli CR, Bitencourt AGV, Morris EA. Is It the Era for Personalized Screening? Radiol Clin North Am 2021;59:129-38. [PMID: 33222994 DOI: 10.1016/j.rcl.2020.09.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Lerner-Ellis J, Mighton C, Lazaro C, Watkins N, Di Gioacchino V, Wong A, Chang MC, Charames GS. Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario. J Cancer Res Clin Oncol 2021;147:871-9. [PMID: 32885271 DOI: 10.1007/s00432-020-03377-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Reid S, Pal T. Update on multi-gene panel testing and communication of genetic test results. Breast J 2020;26:1513-9. [PMID: 32639074 DOI: 10.1111/tbj.13971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Melas M, Subbiah S, Saadat S, Rajurkar S, McDonnell KJ. The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics Considerations. J Clin Med 2020;9:E2125. [PMID: 32640668 DOI: 10.3390/jcm9072125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]